OWLSTONE
LIVE

Serial Number

79239529

Owner

Owlstone Medical Limited

Attorney

Jeffrey R. Gray

Filing Date

Jun 18, 2018

Add to watchlist:

No watchlists yet
View on USPTO

OWLSTONE Trademark

Serial Number: 79239529 • Registration: 5836801

OWLSTONE is a trademark filed by Owlstone Medical Limited on June 18, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Owlstone Medical Limited (15 trademarks)

183 Cambridge Science Park,

Entity Type: 99

Trademark Details

Filing Date

June 18, 2018

Registration Date

August 20, 2019

Published for Opposition

June 4, 2019

Cancellation Date

March 6, 2026

Goods & Services

Scientific and technological services, namely, research and design in the field of computer data storage and interpretation of data; design and development of computer hardware and software; design and development of computer hardware and software for medical and clinical use; medical research services; clinical research in the field of disease biomarkers; chemical analysis undertaken using a spectrometer to analyse disease biomarkers within gas, liquid and solid samples; chemical research; laboratory analysis in the field of chemistry; biological analysis using a spectrometer to analyse disease biomarkers within gas, liquid and solid samples; scientific laboratory services; laboratory testing services of disease biomarkers within gas, liquid and solid samples; medical research laboratory services; computer programming; design and development of medical technology and medical apparatus; research and development services relating to medical apparatus and instruments; advice, information and consultancy relating to any of the aforesaid services

Medical apparatus and instruments for treating cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; diagnostic apparatus for the detection of disease biomarkers; medical apparatus for dosage, measuring and monitoring, namely, drug delivery devices and systems; medical apparatus, namely, breath gas analysers for medical diagnostics; medical apparatus, namely, patient medical monitors for monitoring lung function; medical apparatus, namely, spirometers; medical instruments for measuring and displaying lung capacity; chemical detection systems and apparatus for medical purposes consisting of analysers and sampling equipment for use to collect and analyse liquid, solid and gas samples; medical imaging apparatus; medical devices used for the collection, recording, concentration and analysis of volatile organic compounds in human breath; medical testing kits for detection of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease for home use; testing apparatus for medical purposes, namely, breath detectors for use to detect disease biomarkers; detectors for medical purposes; sensors for medical purposes, namely, respiratory sensors; medical products, namely, biofeedback sensors; patient monitoring sensors and alarms; parts and fittings for all of the aforesaid

Computer hardware and peripheral devices; computer software and computer programs for use to collect and analyse medical samples; computer application software for hand-held computing devices, namely, software to control collection of medical samples and to perform analysis of medical samples; computer software for use to collect and analyse medical samples for use in connection with and as part of medical apparatus and instruments; clinical software, including database systems for patient medical information for use to store and analyse data; medical diagnostic software; computer operating systems; calculating machines and data processing equipment; electronic devices for storing, recording, transmitting and reproducing information, data or images; diagnostic apparatus, not for medical purposes, for use to analyse chemical samples; testing apparatus, not for medical purposes, for use to test calibration of equipment; chemical detection systems and apparatus, namely, analysers and sampling equipment for use to collect and analyse liquid, solid and gas samples; gas detectors, particle detectors; spectrometers; temperature sensors, gas sensors, movement sensors, pressure sensors; computer software and computer programs for medical purposes for use to diagnose and monitor diseases

Medical services; consulting services relating to health care providers in the field of treating life-changing or life-threatening diseases; healthcare services; health advice and information services; medical care services; medical clinic services; medical health assessment services; health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; diagnostic health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; advice, information and consultancy services relating to any of the aforesaid services

Filing History

CANCELLED SECTION 71
Mar 6, 2026 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 20, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 13, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 27, 2019 FICS
FINAL DISPOSITION PROCESSED
Nov 27, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 20, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 20, 2019 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 21, 2019 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Jun 1, 2019 GPNX
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 23, 2019 ADCH
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 15, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 15, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 1, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2019 CRFA
ASSIGNED TO LIE
Mar 29, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 25, 2019 TROA
REFUSAL PROCESSED BY IB
Nov 9, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 25, 2018 RFCS
REFUSAL PROCESSED BY MPU
Oct 25, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 14, 2018 RFCR
NON-FINAL ACTION WRITTEN
Oct 13, 2018 CNRT
ASSIGNED TO EXAMINER
Oct 4, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 30, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 26, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 23, 2018 REPR